June 26, 2020
Carna Biosciences, a Kobe-based drug discovery startup, said on June 25 that it has reached an agreement with Sierra Oncology to recover full worldwide rights to develop, manufacture, and commercialize its CDC7 kinase inhibitor AS-0141 (SRA141), which has been licensed...read more